Request Demo
Recent blog posts
Latest Hotspot
8 min read
CTR20260334 Ethinyl Estradiol/Norelgestromin Contraception Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
CTR20260334 clinical trial report covering Ethinyl Estradiol/Norelgestromin, Phase 3, endpoints, sponsor, geography, readout timing and development white s
Latest Hotspot
8 min read
NCT07387094 Ecnoglutide Sleep Apnea, Obstructive Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07387094 clinical trial report covering Ecnoglutide, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07385703 Tislelizumab Adenocarcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07385703 clinical trial report covering Tislelizumab, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07387549 Elafibranor Cholangitis, Sclerosing Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07387549 clinical trial report covering Elafibranor, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
ChiCTR2600118454 BCG Live(Organon & Co.) Non-Muscle Invasive Bladder Neoplasms Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
ChiCTR2600118454 clinical trial report covering BCG Live(Organon & Co.), Phase 3, endpoints, sponsor, geography, readout timing and development white space
Latest Hotspot
8 min read
CTR20260371 Minocycline Hydrochloride Acne Vulgaris Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
CTR20260371 clinical trial report covering Minocycline Hydrochloride, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07389577 Ranibizumab biosimilar (Jecho Biopharmaceuticals) Wet age-related macular degeneration Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07389577 clinical trial report covering Ranibizumab biosimilar (Jecho Biopharmaceuticals), Phase 3, endpoints, sponsor, geography, readout timing and de
Latest Hotspot
8 min read
NCT07389109 GED-0507-34 Acne Vulgaris Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07389109 clinical trial report covering GED-0507-34, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07389265 Cetuximab Metastatic Colorectal Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07389265 clinical trial report covering Cetuximab, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07389460 Recombinant human prourokinase Acute Ischemic Stroke Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07389460 clinical trial report covering Recombinant human prourokinase, Phase 3, endpoints, sponsor, geography, readout timing and development white spa
Latest Hotspot
8 min read
NCT07388602 Cyclophosphamide Immunoglobulin Light-Chain Amyloidosis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07388602 clinical trial report covering Cyclophosphamide, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07388498 Methotrexate Gout Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07388498 clinical trial report covering Methotrexate, Phase 3, endpoints, sponsor, geography, readout timing and development white space.